— Know what they know.
Not Investment Advice

ALMS NASDAQ

Alumis Inc. Common Stock
1W: -10.0% 1M: -14.4% 3M: -20.7% YTD: +147.4% 1Y: +354.3%
$22.02
-0.15 (-0.68%)
 
Weekly Expected Move ±8.5%
$19 $21 $23 $25 $27
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 31 · $2.7B mcap · 84M float · 1.59% daily turnover · Short 71% of daily vol

Revenue Segmentation

By Product / Service

Income Trends

Revenue
$24M +0.0% ▲
Gross Profit
$21M +752.1% ▲
Operating Income
-$427M -42.0% ▼
Net Income
-$243M +17.3% ▲
EPS (Diluted)
$-2.86 +72.4% ▲
EBITDA
-$424M -42.4% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2022FY2023FY2024FY2025
Revenue$0$0$0$24M
YoY Growth+0.0%+0.0%+0.0%+0.0%
Cost of Revenue$250K$0$3M$3M
Gross Profit-$250K$0-$3M$21M
Gross Margin85.5%
R&D Expenses$101M$138M$266M$386M
SG&A Expenses$13M$20M$35M$92M
Operating Expenses$114M$158M$298M$448M
Operating Income-$114M-$158M-$301M-$427M
Operating Margin-1776.3%
Interest Expense$0$0$0$0
Income Before Tax-$112M-$155M-$294M-$252M
Tax Expense$0$0$0-$9M
Net Income-$112M-$155M-$294M-$243M
Net Margin-1011.7%
EPS (Diluted)$-14.93$-2.99$-10.38$-2.86
EBITDA-$114M-$157M-$298M-$424M
Shares Outstanding7M52M28M850M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms